By Thomas F. Goss, Senior Vice President, Boston Healthcare Associates, Inc. World AIDS Day on the 1st of December is an opportunity for public and private partners to spread awareness about the status of the HIV/AIDS pandemic and encourage continued progress in HIV/AIDS prevention, treatment, and care in high prevalence countries and all countries around [...]
Yesterday the Congressional Budget Office (CBO) released a report describing revised methodology for estimating the financial impact of future legislation affecting prescription drug utilization. From this point forward, CBO analysis of Medicare prescription drug-related policies will assume that a 1% increase in the number of prescriptions filled will lead to a 0.20% decrease in medical [...]
In honor of National Diabetes Awareness Month, we want to share with you the story of a recently diagnosed Type II Diabetes patient and her experience with a prescription assistance program: Rona Evartt of Cottonwood, AZ is a single mother of four and naturally, her children always come first. It wasn’t until her own mother [...]
This week I’m in Boston attending the Harvard Personalized Medicine Conference. (Find out more on the basics of PM here.) Stepping back and listening to the discussion here, it is really inspiring to think about how our understanding of genetics is opening up vast new possibilities for treating and preventing disease. We are already seeing great strides [...]
Today we’ve got a guest post from Dr. Murray Stewart, Senior Vice President, Metabolic Pathways and Cardiovascular, Research & Development of GlaxoSmithKline. Diabetes care for patients is about more than the medicine. People with diabetes are asked to exercise regularly, eat moderately; and importantly, we ask them to work with a collaborative and multi-disciplinary team [...]
We have been tackling the misfortune and suffering caused by HIV/AIDS now for more than 30 years. While great progress has been made in the treatment and prevention of HIV, and many patients now have access to medicines that help them live with and manage the disease, the biopharmaceutical research sector recognizes that much more [...]
AFLCIO.org profiled the successful partnership between organized labor and the biopharmaceutical industry as they work together to foster good jobs and help increase access to high-quality affordable health care. Through the Pharmaceutical Industry Labor-Management Association (PILMA), a growing coalition of pharmaceutical companies and the major building trade unions, the post notes, “such cooperation between workers and the industries [...]
Below is the latest guest post in our “Part D Perspectives” series, which we’ll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 – Dec. 7). Austin Curry, executive director of Elder Care Advocacy of Florida, shares his views on the importance of Part D and what we can to do [...]
Few things exemplify the promise, challenges and opportunities confronting the global biopharmaceutical research sector as do efforts to foster biopharma innovation in China. Dr. John C. Lechleiter, Eli Lilly CEO and PhRMA Chairman, is in China this week as part of PhRMA’s Second Annual China Days. As he travels the country, Dr. Lechleiter is highlighting the growing importance [...]
Today we’ve got a special guest blog post from Dr. John P. Howe III, M.D., President and CEO of Project HOPE. They’re doing some pretty special work in South Africa on diabetes, and I encourage readers to check out their website to learn more. Project HOPE Says Health Education Can Help Communities Win The Battle [...]